within Pharmacolibrary.Drugs.ATC.N;

model N06AX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.478,
    Cl             = 0.4166666666666667,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.00041999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00105,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Oxitriptan (L-5-hydroxytryptophan, 5-HTP) is a naturally occurring amino acid and chemical precursor to serotonin. It has been used as an antidepressant and in the management of conditions related to serotonin deficiency. Oxitriptan is not widely approved as a prescription medication and is more commonly available as a supplement. It is not approved by the FDA for any indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals after oral administration.</p><h4>References</h4><ol><li>,5-hydroxytryptophan.,Alternative medicine review : a journal of clinical therapeutic,1998<a href='https://pubmed.ncbi.nlm.nih.gov/9630740/'>https://pubmed.ncbi.nlm.nih.gov/9630740/</a></li><li>J S Markowitz, C S Brown, T R Moore,Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy.,The Annals of pharmacotherapy,1999<a href='https://pubmed.ncbi.nlm.nih.gov/9972387/'>https://pubmed.ncbi.nlm.nih.gov/9972387/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06AX01;
